Aspira Women's Health Inc. (AWH)
USD 0.77
(1.97%)
USD 0.77
(1.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.49 Million USD | 51.22% |
| 2022 | -30.87 Million USD | -18.41% |
| 2021 | -32.29 Million USD | -79.6% |
| 2020 | -17.71 Million USD | -17.69% |
| 2019 | -14.94 Million USD | -34.81% |
| 2018 | -10.65 Million USD | -8.54% |
| 2017 | -9.65 Million USD | 30.18% |
| 2016 | -14.23 Million USD | 22.31% |
| 2015 | -18.95 Million USD | -0.2% |
| 2014 | -19.07 Million USD | -117.84% |
| 2013 | -8.79 Million USD | 7.83% |
| 2012 | -6.85 Million USD | 45.33% |
| 2011 | -17.31 Million USD | -21.12% |
| 2010 | -18.42 Million USD | -188.96% |
| 2009 | -20.01 Million USD | 62.09% |
| 2008 | -15.4 Million USD | 33.41% |
| 2007 | -17.63 Million USD | -2.54% |
| 2006 | -15.57 Million USD | 29.55% |
| 2005 | -28.13 Million USD | -4.58% |
| 2004 | -26.86 Million USD | 13.71% |
| 2003 | -29.55 Million USD | -16.2% |
| 2002 | -26.14 Million USD | -25.43% |
| 2001 | -22.06 Million USD | -74.71% |
| 2000 | -12.05 Million USD | -114.62% |
| 1999 | -5.68 Million USD | 21.0% |
| 1998 | -6.86 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.36 Million USD | 6.71% |
| 2024 Q1 | -4.68 Million USD | -14.23% |
| 2023 Q3 | -4.11 Million USD | 21.76% |
| 2023 Q1 | -5.74 Million USD | 5.34% |
| 2023 FY | - USD | 51.22% |
| 2023 Q2 | -5.26 Million USD | 8.42% |
| 2023 Q4 | -4.09 Million USD | 0.44% |
| 2022 Q3 | -14.63 Million USD | -79.43% |
| 2022 Q2 | -8.15 Million USD | 11.21% |
| 2022 Q1 | -9.18 Million USD | -3.42% |
| 2022 FY | - USD | -18.41% |
| 2022 Q4 | -6.06 Million USD | 58.53% |
| 2021 Q3 | -9.62 Million USD | -20.46% |
| 2021 Q1 | -5.88 Million USD | 3.1% |
| 2021 Q4 | -8.88 Million USD | 7.72% |
| 2021 Q2 | -7.99 Million USD | -35.75% |
| 2021 FY | - USD | -79.6% |
| 2020 Q3 | -4.21 Million USD | -11.92% |
| 2020 Q2 | -3.76 Million USD | -0.64% |
| 2020 FY | - USD | -17.69% |
| 2020 Q1 | -3.74 Million USD | -9.99% |
| 2020 Q4 | -6.07 Million USD | -44.04% |
| 2019 Q3 | -3.78 Million USD | 10.09% |
| 2019 FY | - USD | -34.81% |
| 2019 Q2 | -4.21 Million USD | -17.22% |
| 2019 Q1 | -3.59 Million USD | -27.3% |
| 2019 Q4 | -3.4 Million USD | 10.16% |
| 2018 Q3 | -2.48 Million USD | 12.68% |
| 2018 Q4 | -2.82 Million USD | -13.6% |
| 2018 FY | - USD | -8.54% |
| 2018 Q1 | -2.83 Million USD | 3.57% |
| 2018 Q2 | -2.84 Million USD | -0.42% |
| 2017 Q3 | -2.3 Million USD | -7.17% |
| 2017 Q2 | -2.14 Million USD | 12.51% |
| 2017 Q1 | -2.45 Million USD | 13.35% |
| 2017 FY | - USD | 30.18% |
| 2017 Q4 | -2.94 Million USD | -27.77% |
| 2016 Q3 | -3.26 Million USD | 8.93% |
| 2016 Q1 | -4.74 Million USD | 4.94% |
| 2016 Q2 | -3.58 Million USD | 24.51% |
| 2016 Q4 | -2.83 Million USD | 13.26% |
| 2016 FY | - USD | 22.31% |
| 2015 FY | - USD | -0.2% |
| 2015 Q4 | -4.99 Million USD | 1.25% |
| 2015 Q3 | -5.05 Million USD | -5.66% |
| 2015 Q2 | -4.78 Million USD | -13.76% |
| 2015 Q1 | -4.2 Million USD | -3.44% |
| 2014 Q2 | -5.52 Million USD | -39.29% |
| 2014 Q3 | -5.55 Million USD | -0.49% |
| 2014 FY | - USD | -117.84% |
| 2014 Q4 | -4.06 Million USD | 26.74% |
| 2014 Q1 | -3.96 Million USD | -118.38% |
| 2013 Q1 | -2.55 Million USD | -86.68% |
| 2013 Q3 | -2.31 Million USD | -10.28% |
| 2013 Q2 | -2.1 Million USD | 17.61% |
| 2013 Q4 | -1.81 Million USD | 21.58% |
| 2013 FY | - USD | 7.83% |
| 2012 Q4 | -1.36 Million USD | 39.8% |
| 2012 Q2 | -3.66 Million USD | -71.57% |
| 2012 FY | - USD | 45.33% |
| 2012 Q1 | -2.13 Million USD | 29.75% |
| 2012 Q3 | -2.26 Million USD | 38.06% |
| 2011 Q4 | -3.03 Million USD | 32.29% |
| 2011 Q1 | -4.41 Million USD | -4.42% |
| 2011 Q3 | -4.48 Million USD | 19.24% |
| 2011 Q2 | -5.55 Million USD | -25.84% |
| 2011 FY | - USD | -21.12% |
| 2010 Q4 | -4.22 Million USD | -18.36% |
| 2010 Q3 | -3.57 Million USD | 3.28% |
| 2010 Q2 | -3.69 Million USD | -25.14% |
| 2010 Q1 | -2.95 Million USD | -106.72% |
| 2010 FY | - USD | -188.96% |
| 2009 Q3 | -601 Thousand USD | 36.54% |
| 2009 FY | - USD | 62.09% |
| 2009 Q4 | -1.42 Million USD | -137.6% |
| 2009 Q2 | -947 Thousand USD | 53.21% |
| 2009 Q1 | -2.02 Million USD | 58.3% |
| 2008 Q1 | -4.2 Million USD | 14.84% |
| 2008 FY | - USD | 33.41% |
| 2008 Q2 | -2.4 Million USD | 42.72% |
| 2008 Q3 | -1.72 Million USD | 28.25% |
| 2008 Q4 | -4.85 Million USD | -181.07% |
| 2007 Q2 | -5.07 Million USD | 4.48% |
| 2007 Q1 | -5.3 Million USD | -710.82% |
| 2007 FY | - USD | -2.54% |
| 2007 Q4 | -4.93 Million USD | -9.23% |
| 2007 Q3 | -4.51 Million USD | 10.91% |
| 2006 Q2 | -6.01 Million USD | -66.32% |
| 2006 Q1 | -3.61 Million USD | 55.25% |
| 2006 Q3 | -5.23 Million USD | 12.97% |
| 2006 Q4 | 869 Thousand USD | 116.6% |
| 2006 FY | - USD | 29.55% |
| 2005 FY | - USD | -4.58% |
| 2005 Q1 | -7.11 Million USD | -64.17% |
| 2005 Q3 | -5.64 Million USD | 18.78% |
| 2005 Q4 | -8.08 Million USD | -43.18% |
| 2005 Q2 | -6.94 Million USD | 2.29% |
| 2004 Q2 | -10.85 Million USD | -125.51% |
| 2004 Q1 | -4.81 Million USD | 3.64% |
| 2004 Q3 | -6.87 Million USD | 36.71% |
| 2004 FY | - USD | 13.71% |
| 2004 Q4 | -4.33 Million USD | 36.94% |
| 2003 Q2 | -13.68 Million USD | -74.39% |
| 2003 Q4 | -4.99 Million USD | -71.65% |
| 2003 Q1 | -7.84 Million USD | -16.13% |
| 2003 Q3 | -3.03 Million USD | 78.73% |
| 2003 FY | - USD | -16.2% |
| 2002 Q3 | -6.71 Million USD | -4.32% |
| 2002 Q4 | -6.75 Million USD | -0.64% |
| 2002 FY | - USD | -25.43% |
| 2002 Q1 | -5.94 Million USD | 2.43% |
| 2002 Q2 | -6.43 Million USD | -8.24% |
| 2001 Q1 | -5.38 Million USD | -30.03% |
| 2001 FY | - USD | -74.71% |
| 2001 Q4 | -6.3 Million USD | -51.19% |
| 2001 Q3 | -6.03 Million USD | 24.5% |
| 2001 Q2 | -5.33 Million USD | 0.91% |
| 2000 Q1 | 1.82 Million USD | 0.0% |
| 2000 Q2 | 1.82 Million USD | 0.05% |
| 2000 Q4 | -4.14 Million USD | 34.39% |
| 2000 Q3 | -6.23 Million USD | -446.79% |
| 2000 FY | - USD | -114.62% |
| 1999 FY | - USD | 21.0% |
| 1998 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 92.28% |
| Prenetics Global Limited | -47.89 Million USD | 65.569% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -877.534% |
| CareDx, Inc | -89.65 Million USD | 81.607% |
| Exact Sciences Corporation | 41.87 Million USD | 139.381% |
| Exagen Inc. | -19.15 Million USD | 13.899% |
| Inotiv, Inc. | -26.5 Million USD | 37.784% |
| Guardant Health, Inc. | -433.3 Million USD | 96.194% |
| Biodesix, Inc. | -37.1 Million USD | 55.553% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -563.579% |
| Precipio, Inc. | -4.31 Million USD | -281.913% |
| iSpecimen Inc. | -9.1 Million USD | -81.146% |
| Natera, Inc. | -383.27 Million USD | 95.697% |
| Standard BioTools Inc. | -54.45 Million USD | 69.717% |
| 23andMe Holding Co. | -291.87 Million USD | 94.35% |
| Castle Biosciences, Inc. | -45.02 Million USD | 63.373% |
| Personalis, Inc. | -96.8 Million USD | 82.965% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 85.973% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -71.942% |
| OpGen, Inc. | -29.51 Million USD | 44.119% |
| T2 Biosystems, Inc. | -43.87 Million USD | 62.414% |
| Myriad Genetics, Inc. | -67.8 Million USD | 75.677% |
| ICON Public Limited Company | 1.63 Billion USD | 101.011% |
| NeoGenomics, Inc. | -17.6 Million USD | 6.338% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -877.534% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 101.354% |
| RadNet, Inc. | 292.78 Million USD | 105.632% |
| MDxHealth SA | -30.46 Million USD | 45.874% |
| Psychemedics Corporation | -251 Thousand USD | -6470.12% |
| Illumina, Inc. | -608 Million USD | 97.288% |
| Check-Cap Ltd. | -17.64 Million USD | 6.561% |
| Twist Bioscience Corporation | -176.7 Million USD | 90.667% |
| DarioHealth Corp. | -53.49 Million USD | 69.172% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 64.575% |
| Sera Prognostics, Inc. | -35.28 Million USD | 53.266% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -68.537% |
| OPKO Health, Inc. | -65.51 Million USD | 74.829% |
| Medpace Holdings, Inc. | 363.15 Million USD | 104.541% |
| Neogen Corporation | 182.59 Million USD | 109.031% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -87.17% |
| Prenetics Global Limited | -47.89 Million USD | 65.569% |
| Mainz Biomed B.V. | -25.01 Million USD | 34.066% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -116.153% |
| Trinity Biotech plc | -24.09 Million USD | 31.567% |
| Neuronetics, Inc. | -22.75 Million USD | 27.541% |
| Sotera Health Company | 514.14 Million USD | 103.207% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -116.153% |